Jihui Hao Selected Research

Jihui Hao Research Topics

Disease

45	Neoplasms (Cancer) 02/2022 - 04/2007
32	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 06/2010
18	Adenocarcinoma 01/2022 - 01/2012
12	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
12	Hypoxia (Hypoxemia) 01/2019 - 09/2011
3	Lung Neoplasms (Lung Cancer) 10/2021 - 10/2019
2	Carcinogenesis 01/2022 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 10/2014
1	Genomic Instability 01/2022
1	Embolism (Embolus) 01/2022
1	Carcinoma (Carcinomatosis) 10/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Atrophy 01/2021
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Adenocarcinoma of Lung 12/2019
1	Cancer Pain 01/2019
1	Triploidy 03/2017
1	Circulating Neoplastic Cells 03/2017
1	Blindness (Hysterical Blindness) 12/2016
1	Hearing Loss (Hearing Impairment) 12/2016
1	Disease Progression 10/2016
1	Leukemia 10/2016
1	Fibrosis (Cirrhosis) 02/2016
1	Esophageal Squamous Cell Carcinoma 12/2015

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2010
12	Gemcitabine FDA Link 01/2022 - 02/2015
7	Messenger RNA (mRNA)IBA 01/2021 - 04/2007
6	ChromatinIBA 02/2022 - 01/2012
6	Biomarkers (Surrogate Marker)IBA 02/2022 - 10/2014
6	Pharmaceutical PreparationsIBA 01/2017 - 02/2015
4	fascinIBA 10/2021 - 05/2014
3	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2015
3	LipidsIBA 01/2022 - 04/2015
3	2- amino- 3- (4'- N,N- bis(2- chloroethyl)amino)phenylpropionic acid N-oxideIBA 09/2019 - 02/2015
3	AntigensIBA 01/2019 - 03/2014
3	Liposomes (Liposome)IBA 01/2019 - 02/2016
3	LuciferasesIBA 01/2017 - 01/2012
3	Stem Cell FactorIBA 01/2017 - 10/2014
3	Transcription Factors (Transcription Factor)IBA 10/2016 - 09/2011
2	RNA (Ribonucleic Acid)IBA 02/2022 - 01/2015
2	Albumin-Bound Paclitaxel FDA Link 01/2022 - 06/2021
2	PolymersIBA 01/2022 - 04/2015
2	CollagenIBA 01/2021 - 02/2016
2	Chelating AgentsIBA 01/2020 - 01/2019
2	IronIBA 01/2020 - 01/2019
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2020 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2013
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019 - 01/2019
2	InterleukinsIBA 01/2018 - 01/2017
2	pirfenidoneIBA 01/2017 - 02/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 03/2015
2	HydrogelsIBA 03/2015 - 01/2015
2	LeptinIBA 11/2014 - 03/2010
1	HeterochromatinIBA 02/2022
1	EuchromatinIBA 02/2022
1	mitochondrial calcium uniporterIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Rosiglitazone (Avandia)FDA Link 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	CalciumIBA 01/2022
1	7- methyl- 5- (1- ((3- (trifluoromethyl)phenyl)acetyl)- 2,3- dihydro- 1H- indol- 5- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 4- amineIBA 01/2022
1	Cystine (L-Cystine)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2021
1	folfirinoxIBA 06/2021
1	oil red OIBA 01/2021
1	PlasticsIBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	AntibodiesIBA 01/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2020
1	Doxycycline (Periostat)FDA LinkGeneric 12/2019
1	deoxyguanosine kinaseIBA 12/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2019
1	Pregnenolone Carbonitrile (PCN)IBA 02/2018
1	CarbohydratesIBA 02/2018
1	Neutralizing AntibodiesIBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 12/2017
1	cyclohexane- 1,2,4- tris(methylenesulfonate) (CTMS)IBA 03/2017
1	LY3009120IBA 01/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	CytokinesIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016
1	Blood Proteins (Serum Proteins)IBA 10/2016
1	Arsenic Trioxide (Trisenox)FDA Link 10/2016
1	CA-125 Antigen (CA 125 Antigen)IBA 03/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2016
1	CyclodextrinsIBA 02/2016
1	arginyl-glycyl-aspartic acidIBA 02/2016

Therapy/Procedure

10	Therapeutics 06/2021 - 06/2010
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2012
3	Immunotherapy 01/2021 - 01/2016
1	Adjuvant Chemotherapy 01/2022
1	Nutrition Therapy (Medical Nutrition Therapy) 01/2021
1	Injections 01/2018
1	Radiotherapy 12/2015